Sort
23,748 grants matching “melanoma”
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model
$598,999Ryan C Fields · Washington University · R01 · FY2021 · CA
Regulators of Cancer Immunotherapy Response
$598,991Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy
$598,805Rohan Fernandes · George Washington University · R01 · FY2024 · CA
A plasticity and reprogramming paradigm for therapy resistance at the single cell level
$598,501Arjun Raj · University Of Pennsylvania · U01 · FY2018 · CA
Technetium and Rhenium in Nuclear Medicine
$598,352Alun Gareth Jones · Harvard Medical School · R01 · FY2006 · CA
Novel IL-15 Superagonist Therapy for Bladder Cancer
$598,323Hing C. Wong · Altor Bioscience. Llc · R44 · FY2014 · CA
Novel IL-15 Superagonist Therapy for Bladder Cancer
$598,323Hing C. Wong · Altor Bioscience. Llc · R44 · FY2015 · CA
Gene Therapy for Human Malignant Melanoma
$598,308Introgen Therapeutics, Inc. · R42 · FY2005 · CA
Engineering synthetic feedback control in T cell signaling for anti-tumor immunity
$598,275Hao Yuan Kueh · Yale University · R01 · FY2025 · CA
Facebook Intervention for Young Onset Melanoma Patients and Families
$598,244Sharon L Manne · Rbhs -Cancer Institute Of New Jersey · R01 · FY2018 · CA
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
$598,220Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2022 · CA
Community Outreach and Engagement
$598,066Simona Kwon · New York University School Of Medicine · P30 · FY2025 · CA
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure
$598,023Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2019 · CA
Light-sheet Microscope for Imaging Developmental Processes and Cleared Tissues
$597,999James Alexander Fitzpatrick · Washington University · S10 · FY2019 · OD
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
$597,883Ashani T Weeraratna · Wistar Institute · R01 · FY2019 · CA
A Novel Therapeutic Strategy for Ovarian Cancer
$597,841Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Neuroimmune Mechanisms of Depressive-Like Behavior During Aging
$597,835Keith W. Kelley · University Of Illinois At Urbana-Champaign · R01 · FY2011 · AG
THE GENETICS OF OCULAR MELANOMA
$597,690Anne Mary Bowcock · Washington University · R01 · FY2011 · CA
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer
$597,684H. Steven Wiley · Battelle Pacific Northwest Laboratories · U01 · FY2021 · CA
RIG-I Activating Nanoparticles for Immunopotentiation
$597,471John Tanner Wilson · Vanderbilt University · R01 · FY2025 · EB
Targeting B7-H3 in ovarian cancer
$597,170Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
The Oncogene Activated Mitochondrial Unfolded Protein Response Regulates Senescence Biology
$597,164Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
PDX Core
$597,131Clemens Krepler · Wistar Institute · U54 · FY2017 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$596,948Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Metabolic Targets in Pten-Tumors
$596,888Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · CA